Apyx Medical extends property sale inspection period to May 4, 2023, closing to May 8

First Amendment to Purchase and Sale Agreement, dated April 12, 2023 : As previously reported by Apyx Medical Corporation (the “Company”) in a Current Report on Form 8-K filed with the Securities and Exchange Commission on March 15, 2023, on March 14, 2023 the Company entered into a Purchase and Sale Agreement (the “Purchase Agreement”) with VK Acquisitions VI, LLC (the “Purchaser”), for the sale of the Company’s facility located at 5115 Ulmerton Road, Clearwater, Florida, as more fully described in the Purchase Agreement (collectively, the “Property”) for a purchase price of $7,650,000. Pursuant to the terms of the Purchase Agreement, the Purchaser initially had thirty (30) days from the date of execution to complete its satisfactory due diligence of the Property (the “Inspection Period”), during which time the Purchaser retained the right to cancel the Purchase Agreement. The initial closing of the transaction was to be held five (5) days following the expiration of the Inspection Pe